Anavex Life Sciences Corp.AVXLNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank87
3Y CAGR+2.0%
5Y CAGR+7.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+2.0%/yr
vs +15.2%/yr prior
5Y CAGR
+7.3%/yr
Recent deceleration
Acceleration
-13.1pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$12.80M-7.4%
2025$13.82M+25.2%
2024$11.04M-8.4%
2023$12.05M-7.8%
2022$13.07M+44.9%
2021$9.02M+54.0%
2020$5.86M-14.5%
2019$6.85M+14.3%
2018$5.99M+19.6%
2017$5.01M-